Panbela Therapeutics Inc (STU:X70)
€ 119.4 0 (0%) Market Cap: 1.71 Mil Enterprise Value: 4.14 Mil PE Ratio: 0 PB Ratio: 0 GF Score: 28/100

Q2 2023 Panbela Therapeutics Inc Earnings Call Transcript

Aug 10, 2023 / 08:30PM GMT
Release Date Price: €119.4
Operator

Greetings, and welcome to the Panbela Therapeutics second quarter 2023 earnings call. (Operator Instructions) Please note this conference is being recorded.

I will now turn the conference over to your host, James Carbonara, Investor Relations at Panbela. James, you may begin.

James Carbonara
Hayden IR - IR

Thank you, operator. With me on the call are Jennifer Simpson, Chief Executive Officer; and Sue Horvath, Chief Financial Officer.

Before I turn the call over to Dr. Simpson, please note that statements made on this call that are not historical facts may be forward-looking statements. Significant risks and uncertainties that could cause actual results to differ from those expressed or implied in the forward-looking statements are detailed in the company's annual report on Form 10-K, and supplemented by subsequently filed quarterly reports on Form 10-Q, as well as in other reports that the company has filed with the SEC.

Any forward-looking statements made on this call are made only as of today's date, and the company does not

Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis
30-Year Financial on one screen
All-in-one Stock Screener with unlimited filters
Customizable Stock Dashboard
Real Time Insider Trading Transactions
8,000+ Institutional investors’ 13F holdings
Powerful Excel Add-in and Google sheets Add-on
All data downloadable
Quick customer support
And much more...
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot